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of the Martian surface
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Physiological and Anatomical Rodent Experiment / National Institutes of 
Health-Rodents (PARE/NIH-R) behavioral changes and the development of 
muscle, bone, nervous, and circadian timing systems in rats exposed to 
microgravity in utero. This project emphasized features of the rat's behavior and 
physiology that are known to contribute to successful pregnancy, labor, delivery and the onset 
of postnatal care, especially lactation. In addition, examination of the offspring after birth is 
expected to provide information about the earliest development of the vestibular system under 
gravity as compared to microgravity conditions.
Commercial Protein Crystal Growth (CPCG)
Biological Research in Canisters (BRIC BRIC-04 experiments were 
specifically designed to examine how the hormone system and muscle 
formation processes of the tobacco hornworm are affected an altered 
gravitational field. BRIC experiment specimens were exposed to the temperatures, 
carbon dioxide, oxygen, atmospheric pressure and humidity conditions of the middeck.
Bioreactor Demonstration System (BDS)
Space Tissue Loss/National Institutes of Health-Cells (STL/NIH-C) the 
effects of microgravity on embryogenesis in the Medaka fish egg at the 
molecular level. Of particular interest was the digital image capture of the gastrulation
development phase; images were captured via the STL-B on board video microscope and 
telemetered to investigators on the ground. This follow-up experiment helped validate previous 
findings, as well as provided additional definition to the model for future space biology 
experimentation.
Spaceflight in humans alters autonomic regulation of arterial pressure
JANICE M. FRITSCH-YELLE, JOHN B. CHARLES, MICHELE M. JONES, LARRY A. 
BEIGHTOL, AND DWAIN L. ECKBERG
J. Appl. Physiol. 77(4): 1776-1783,1994
Spaceflight is associated with decreased orthostatic tolerance after landing. Short-duration 
spaceflight (4-5 days) impairs one neural mechanism: the carotid baroreceptor-cardiac reflex. 
To understand the effects of longer-duration spaceflight on baroreflex function, we measured 
R-R interval power spectra, antecubital vein plasma catecholamine levels, carotid 
baroreceptor-cardiac reflex responses, responses to Valsalva maneuvers, and orthostatic 
tolerance in 16 astronauts before and after shuttle missions lasting 8-14 days. We found the 
following changes between preflight and landing day: 1) orthostatic tolerance decreased 2; ) 
R-R interval spectral power in the 0.05 to 0.15 Hz band increased; 3) plasma norepinephrine 
and epinephrine levels increased; 4) the slope, range, and operational point of the carotid 
baroreceptor cardiac reflex response  decreased and 5) blood pressure and heart rate 
responses to Valsalva maneuvers were altered. Autonomic changes persisted for several 
days after landing. These results provide further evidence of functionally relevant reductions 
in parasympathetic and increases in sympathetic influences on arterial pressure control after 
spaceflight. 
Other life sciences experiments performed during the 
STS-70 mission were space motion sickness, 
cardiovascular deconditioning, muscle loss, changes in 
coordination and balance strategies, radiation exposure, 
pharmacokinetics and changes in the body's 
biochemistry.
Decreased gravity makes body fluids shift upward 
Physiology in Space 
Head Congestion
Physiology in Space 
“In space, you’re always on the verge of a headache.”
David Wolf
Decreased gravity makes body 
fluids shift upward 
Physiology in Space 
Regulation of Body Fluid and Salt Homeostasis –
from Observations in Space to New Concepts on Earth
R. Gerzer* and M. Heer Current Pharmaceutical Biotechnology, 2005, 6, 299-304 299
Cardiovascular Changes in Spaceflight
Tracings during a 
tilt test from an 
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Waters, Wendy W., Michael G. Ziegler, and Janice V. 
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mostly in women and is predicted by low vascular 
resistance. J Appl Physiol 92: 586–594, 2002. 
Plasma norepinephrine (top) and 
epinephrine (bottom) responses in 
women (n  4; black bars), presyncopal
men (n  6; light gray bars), and 
nonpresyncopal men (n  22; dark gray 
bars) when tested preflight (A), on 
landing day (B), and 3 days 
postspaceflight (C). Values are means  
SE. †P  0.058. *P  0.05. **P  0.01
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Decreased gravity disrupts the sense of balance
Physiology in Space 
http://www.skybrary.aero/index.php/Vestibular_System_and_Illusions_(OGHFA_BN)
Space Motion Sickness (Space Adaptation Syndrome)
Physiology in Space 
Am J Med. 2001 Dec 3;111 Suppl 8A:106S-112S.
Central neurocircuitry associated with emesis. Hornby PJ.
Body Pain
Physiology in Space 
Circadian Rhythm Disruption
Physiology in Space 
Russian ground personal members 
and doctors carry Italian ESA 
astronaut Roberto Vittori to the 
medical tent upon his arrival to the 
town of Arkalyk, northern 
Kazakhstan, early Monday, April 25, 
2005. [AP]
Physiology in Space 
First pharmaceuticals in US spaceflight
1963 Mercury Atlas 9
Gordon Cooper carried 
pre-loaded drug injectors 
in space suit pocket
Demerol – pain relief
Tigan - motion sickness
Pharmaceutical Use on Shuttle 

Our Mission at the 
JSC Pharmacology Lab…
…to ensure that flight surgeons have good information 
about how administered pharmaceuticals will work in the 
extreme conditions of spaceflight
…which means that we have to understand the 
physiological changes caused by living in the spaceflight 
environment
…as well as the effect of the spaceflight environment on 
the stored drugs themselves
…as well as the pharmaceuticals’ mechanism of action
1. Design experiment to answer the 
scientific question. 
2. Book the appropriate time in 
NASA’s top-secret low-gravity 
chamber on Earth.
3. Analyze results and make 
recommendations to flight 
medicine.
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Autoclave
Limitations of spaceflight experiments:
 Non-invasive methods best
 Non-toxic
 Lightweight and small equipment
 No degassing, explosion or fire risk
 Low power consumption
 Low impact on crew schedule
 N will be small (350 people have flown to space)
Blood collection kit for Space Lab 1, 1981
Inside the science module 
aboard the Earth-orbiting Space 
Shuttle Columbia, Astronaut 
David A. Wolf draws blood from 
payload specialist Martin J. 
Fettman, DVM. Blood samples 
from crew members are critical 
to Life Sciences investigations

ISS commander and science 
officer Leroy Chiao performs an 
ADUM scan on the eye of flight 
engineer Salizhan Sharipov
Durin during ISS Expedition 10.
The eight holes on this chip are ports that 
can be filled with fluids or chemicals. Tiny 
valves control the chemical processes by 
mixing fluids that move in the tiny channels 
that look like lines, connecting the ports. 
Scientists at NASA's Marshall Space Flight 
Center in Huntsville, Alabama designed 
this chip to grow biological crystals on the 
ISS. These chips, the size of dimes, could 
be loaded on a rover looking for 
biosignatures of past or present life. Other 
types of chips could be placed in handheld 
devices used to monitor microbes in 
water or to quickly conduct medical tests 
on astronauts. (NASA/MSFC/D.Stoffer)
Before 1988, there were no countermeasures 
except fluid loading and g suits. 
Shuttle missions lasted no more than 7 days. 
In 1988 Congress approved funds to expand missions to 16 days. 
Countermeasure development began in earnest. 
Currently, 3 months on the ISS is routine. 
Now, we are starting to think about longer duration missions, 
and the countermeasures that will be required to 
maintain crew health over periods of years. 
NASA Flight Analogs Project models fluid shifts, 
lack of gravitation force on bone & muscle
 Head-down Tilt Bed Rest
– serves as a model for 
studying the 
physiological changes 
that occur during 
spaceflight under 
controlled conditions;
– provides a platform for 
comparison between 
bed rest and spaceflight;
– provides a mechanism 
for testing 
countermeasures prior to 
being used in flight.
http://www.bedreststudy.com
Pillownaut blogs
2 weeks of pre-testing 
30, 60 or 90 days in bed 
Specimens, samples and 
testing
2 weeks of post testing
All activities are done in bed
Standardized diet is consumed
Sleep/Wake cycle
Wake at 0600 hrs
Lights out at 2200 hrs 
The rotating chair is 
powered by a Neuro
Kinetics, Inc. (NKI) 160 ft 
lb Continuous Torque/320 
ft lb Peak Torque 
servomotor rate table. An 
integrated low noise 
mechanical bearing 
system provides quiet 
operation with high loads. 
The chair has a maximum 
velocity up to 360 
degrees/second .
www.graybiel.brandeis.edu/.../facilities.html
Motion sickness is used to model 
space motion sickness
Dr. Cheryl Nickerson is studying the effects of 
simulated low-g on a well-known pathogen, 
Salmonella typhimurium, a bacterium that 
causes two to four million cases of 
gastrointestinal illness in the United States each 
year. While most healthy people recover readily, 
S. typhimurium can kill people with weakened 
immune systems. Thus, a simple case of food 
poisoning could disrupt a space mission. Using 
the NASA rotating-wall bioreactor, Nickerson 
cultured S. typhimurium in modeled microgravity. 
Mice infected with the bacterium died an 
average of three days faster than the control 
mice, indicating that S. typhimurium's virulence 
was enhanced by the bioreactor. Earlier 
research showed that 3 percent of the genes 
were altered by exposure to the bioreactor.
Culture systems are used to measure 
changes at the cellular level
STS-65 (1994) Mission Specialist 
Donald A. Thomas is seen in the 
spacelab science module making an 
observation of one of the newts. 
Smaller organisms, such as the newts, 
are able to develop from embryos and 
hatch during the mission as part of an 
overall program to determine if 
development occurs normally in the 
space environment. 
Animals can be used as research subjects
 The 5HT-3 antagonists revolutionized cancer 
chemotherapy, but are no more effective then placebo 
for motion-induced illness. 
 NASA uses promethazine and scopolamine for treating 
space motion sickness, but there are side effects. 
Motion Sickness Treatments
Space Motion Sickness:
Treatment exacerbates 
presyncope at landing 
People who may have experienced bone loss 
are at a greater risk of serious injury in a fall. 
A side effect of promethazine treatment is orthostatic 
hypotension and presyncope.  Shi, et al, 2010
Space Motion Sickness:
Treatment leads to sedation?
Research questions:
Are there other space motion sickness treatments that 
don’t have this side effect? 
Is there a countermeasure we can implement?
Promethazine can impair performance to a 
degree similar to alcohol. Cowings et al., 1996
Sleep aids:
what happens in a night emergency? 
Will the crew be groggy and slow to respond? 
Will their performance be impaired by the medication?
Research questions:
Determine the best sleep aids to use, 
that balance efficacy with residual impairment
Test possible emergency antidotes to sleep medications
 Longer duration missions will require extended drug 
stability.
 NASA has initiated experiments to measure the rate of 
decay of pharmaceuticals in flight. 
Expiration
 Materials – protect from light, vibration, oxygen, radiation? 
 Low bulk
 Low out-gassing
 Oxygen and humidity scavenging
 Usage tracking
Packaging
General NASA info: http://www.nasa.gov
Human Research at NASA: http://humanresearch.jsc.nasa.gov/
Lab job openings through Wyle:  http://careers.wylelabs.com/
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